NDC 70771-1714 – Dapagliflozin
Dapagliflozin 5 mg/1 · Tablet · Oral
Product NDC70771-1714
Product details
- Brand name
- Dapagliflozin
- Generic name
- Dapagliflozin
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA211582
- Marketed since
- April 6, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Sodium-Glucose Cotransporter 2 Inhibitor
Active ingredients
- Dapagliflozin 5 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 70771-1714-3 | 30 TABLET in 1 BOTTLE (70771-1714-3) | Apr 6, 2026 |
| 70771-1714-9 | 90 TABLET in 1 BOTTLE (70771-1714-9) | Apr 6, 2026 |
Other Dapagliflozin products
- 27241-151 Dapagliflozin 5 mg/1 · Tablet · Ajanta Pharma USA Inc.
- 27241-152 Dapagliflozin 10 mg/1 · Tablet · Ajanta Pharma USA Inc.
- 71921-420 Dapagliflozin 5 mg/1 · Tablet · Florida Pharmaceutical Products, LLC
- 71921-421 Dapagliflozin 10 mg/1 · Tablet · Florida Pharmaceutical Products, LLC
- 70748-106 Dapagliflozin 10 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 70748-105 Dapagliflozin 5 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 33342-585 Dapagliflozin 5 mg/1 · Tablet · Macleods Pharmaceuticals Limited
- 33342-586 Dapagliflozin 10 mg/1 · Tablet · Macleods Pharmaceuticals Limited
- 67296-2334 Dapagliflozin 10 mg/1 · Tablet · Redpharm Drug
- 70771-1715 Dapagliflozin 10 mg/1 · Tablet · Zydus Lifesciences Limited
- 70710-1380 Dapagliflozin 5 mg/1 · Tablet · Zydus Pharmaceuticals USA Inc.
- 70710-1381 Dapagliflozin 10 mg/1 · Tablet · Zydus Pharmaceuticals USA Inc.